AU2001291195A1 - Nucleotide and protein sequence of helios 3 and methods of use - Google Patents

Nucleotide and protein sequence of helios 3 and methods of use

Info

Publication number
AU2001291195A1
AU2001291195A1 AU2001291195A AU9119501A AU2001291195A1 AU 2001291195 A1 AU2001291195 A1 AU 2001291195A1 AU 2001291195 A AU2001291195 A AU 2001291195A AU 9119501 A AU9119501 A AU 9119501A AU 2001291195 A1 AU2001291195 A1 AU 2001291195A1
Authority
AU
Australia
Prior art keywords
helios
nucleotide
methods
protein sequence
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001291195A
Inventor
Hoshnuwar Kerawalla
Lei Sun
Fatih M. Uckun
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Parker Hughes Institute
Original Assignee
Parker Hughes Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Parker Hughes Institute filed Critical Parker Hughes Institute
Publication of AU2001291195A1 publication Critical patent/AU2001291195A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57426—Specifically defined cancers leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
AU2001291195A 2000-12-01 2001-09-21 Nucleotide and protein sequence of helios 3 and methods of use Abandoned AU2001291195A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25062200P 2000-12-01 2000-12-01
US60250622 2000-12-01
PCT/US2001/029679 WO2002044372A2 (en) 2000-12-01 2001-09-21 Nucleotide and protein sequence of helios 3 and methods of use

Publications (1)

Publication Number Publication Date
AU2001291195A1 true AU2001291195A1 (en) 2002-06-11

Family

ID=22948497

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001291195A Abandoned AU2001291195A1 (en) 2000-12-01 2001-09-21 Nucleotide and protein sequence of helios 3 and methods of use

Country Status (2)

Country Link
AU (1) AU2001291195A1 (en)
WO (1) WO2002044372A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI793151B (en) 2017-08-23 2023-02-21 瑞士商諾華公司 3-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof
JOP20210001A1 (en) 2018-07-10 2021-01-05 Novartis Ag 3-(5-hydroxy-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and their use in the treatment of ikaros family zinc finger 2 (ikzf2)-dependent diseases
AR116109A1 (en) 2018-07-10 2021-03-31 Novartis Ag DERIVATIVES OF 3- (5-AMINO-1-OXOISOINDOLIN-2-IL) PIPERIDINE-2,6-DIONA AND USES OF THE SAME

Also Published As

Publication number Publication date
WO2002044372A2 (en) 2002-06-06

Similar Documents

Publication Publication Date Title
AU2001277172A1 (en) Bstp-trans protein and related reagents and methods of use thereof
AU1194802A (en) DNA expression vectors and methods of use
AU2002225954A1 (en) Dipeptidylpeptidases and methods of use
HK1053673A1 (en) Methods of protein destabilization and uses thereof
AU2001278011A1 (en) Bstp-ecg1 protein and related reagents and methods of use thereof
AU2002246808A1 (en) Human nucleic acids and polypeptides and methods of use thereof
AU6585498A (en) Novel uncoupling protein and methods of use
AU4992299A (en) Uncoupling protein 4 (ucp-4) and methods of use
AP2001002189A0 (en) Genes and proteins and their uses
AU2001277202A1 (en) Bstp-ras/rerg protein and related reagents and methods of use thereof
IL154357A0 (en) Stress proteins and peptides and methods of use thereof
AU2001274566A1 (en) Novel protein and dna thereof
AU2001291195A1 (en) Nucleotide and protein sequence of helios 3 and methods of use
AU2001249692A1 (en) Phospholipid scramblases and methods of use thereof
AU2001297556A1 (en) 38650, 28472, 5495, 65507, 81588 and 14354 methods and compositions of human proteins and uses thereof
AU2001268053A1 (en) Human sparc-homologous (hsparc-h1) gene and methods and uses thereof
AU2001264934A1 (en) Dna repair polypeptides and methods of use
AU1856297A (en) Lyst1 and lyst2 gene compositions and methods of use
AU2001266813A1 (en) Human proteins and nucleic acids encoding same
GB0020952D0 (en) Genes and proteins and their uses
AU5634400A (en) Shank proteins and methods of use thereof
AU6580598A (en) (noey2) gene compositions and methods of use
AU3411999A (en) Novel rnase-like protein and its use
AU2001263287A1 (en) Human protein kinase "13305" and uses therefor
AU2002245158A1 (en) Human proteins 55562 and 21617, and methods of use thereof